Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

11.1%

1 terminated/withdrawn out of 9 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

17%

1 of 6 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

5(55.6%)

Phase 2

2(22.2%)

Phase 4

1(11.1%)

N/A

1(11.1%)

9Total

Phase 1(5)

Phase 2(2)

Phase 4(1)

N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04932265Phase 1Suspended

Effect of Gamma-cyclodextrin on the Bioavailability of Ginsenosides

Role: lead

NCT04918667Phase 1Not Yet Recruiting

Effect of Gamma-cyclodextrin on the Bioavailability of Berberine

Role: lead

NCT03463018Phase 2Terminated

Echinacea Angustifolia (AnxioCalm) in Anxiety

Role: lead

NCT04167449Phase 4Completed

Effects of Korean Red Ginseng Extract on Electrical Brain Activity in Elderly Subjects

Role: lead

NCT03461380Phase 2Completed

Effect of Menopause Relief EP-40 in Women With Menopausal Symptoms

Role: lead

NCT02978339Phase 1Completed

A Study Evaluating the Safety and Efficacy of Curcumin in Patients With Primary Sclerosing Cholangitis (PSC)

Role: collaborator

NCT03780621Phase 1Completed

Effects of an Adaptogenic Extract on Electrical Activity of the Brain in Elderly Subjects With Cognitive Impairment

Role: lead

NCT03947554Phase 1Completed

Ginseng HRG80 in Stress and Fatigue

Role: lead

NCT02390349Not ApplicableCompleted

"CuraMed" and "Curamin" in Osteoarthritis

Role: lead

All 9 trials loaded